In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders.
Saved in:
| Title: | In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders. |
|---|---|
| Authors: | Rorick-Kehn, Linda M.1 RorickKehnLM@lilly.com, Johnson, Bryan G.1, Knitowski, Karen M.1, Salhoff, Craig R.1, Witkin, Jeffrey M.1, Perry, Kenneth W.1, Griffey, Kelly I.1, Tizzano, Joseph P.2, Monn, James A.1, McKinzie, David L.1, Schoepp, Darryle D.1 |
| Source: | Psychopharmacology. Jul2007, Vol. 193 Issue 1, p121-136. |
| Database: | SPORTDiscus with Full Text |
Be the first to leave a comment!
